Login

FDA OKs allergy shot

photo.caption|escapejs

TRENTON, N.J. -- U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed.

This story is only available from our archives.

Log in to comment